Literature DB >> 2001474

Role of the local renin-angiotensin system in the autoregulation of the cerebral circulation.

O B Paulson1, G Waldemar.   

Abstract

Inhibition of angiotensin-converting enzyme (ACE) shifts the limits of cerebral blood flow autoregulation toward lower blood pressure values. This effect seems to be mediated by blocking the formation of angiotensin II on the luminal side of the larger cerebral resistance vessels. Baseline cerebral blood flow (the flow within the autoregulatory limits) is not changed by acute or chronic ACE inhibition. An interaction between the vascular reninangiotensin and the sympathetic nervous system is present. Activation of the latter inhibits the downwards shift of the upper limit of autoregulation following ACE inhibition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001474     DOI: 10.1159/000158867

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  7 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

Review 2.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

3.  Cerebral Autoregulation Real-Time Monitoring.

Authors:  Adi Tsalach; Eliahu Ratner; Stas Lokshin; Zmira Silman; Ilan Breskin; Nahum Budin; Moshe Kamar
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

4.  Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation.

Authors:  Anand R Nair; Larry N Agbor; Masashi Mukohda; Xuebo Liu; Chunyan Hu; Jing Wu; Curt D Sigmund
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

5.  Neonatal cerebral blood flow velocity responses to changes in posture.

Authors:  M Y Anthony; D H Evans; M I Levene
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

Review 6.  Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

7.  Impact of short-term treatment with telmisartan on cerebral arterial remodeling in SHR.

Authors:  Sébastien Foulquier; Isabelle Lartaud; François Dupuis
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.